Literature DB >> 12490609

Effects of FK506 on [Ca2+]i differ in mouse and rabbit ventricular myocytes.

Zhi Su1, Kazuro Sugishita, Fenghua Li, Michael Ritter, William H Barry.   

Abstract

FK506 binding proteins (FKBPs 12 and 12.6) interact with ryanodine receptor (RyR) and modulate its functions. FK506 binds to and reverses effects of FKBP on RyR, thus increasing RyR sensitivity to Ca2+, decreasing RyR cooperativity, and increasing RyR open probability. FK506 would thus be expected to have an effect on excitation-contraction coupling, but which of these FK506 effects predominates and how the [Ca2+]i transient would be altered are difficult to predict. FK506 has been reported to increase the [Ca2+]i transient in rat myocytes, but effects in other species have not been described. We compared the effects of FK506 on [Ca2+]i transients, L-type Ca2+ channel and Na/Ca exchange currents, membrane potential, and sarcoplasmic reticulum (SR) Ca2+ content in adult mouse and rabbit ventricular myocytes (VM). FK506 (10 microM) increased the [Ca2+]i transient in mouse VM (656 +/- 116 to 945 +/- 144 nM, p < 0.001) but decreased the amplitude of [Ca2+]i transients in rabbit VM (627 +/- 61 to 401 +/- 37 nM, p < 0.001). Similar effects were observed with rapamycin. The effects of FK506 and rapamycin on [Ca2+]i transients in VM of both species were reversible upon washout. FK506 did not alter SR Ca2+ content in mouse VM (0.79 +/- 0.1 versus 0.78 +/- 0.1 pC/pF) but reduced the SR Ca2+ content in rabbit VM (0.43 +/- 0.05 versus 0.30 +/- 0.04 pC/pF, P < 0.05) [pC = the integral (pA. s) of the caffeine-induced inward I(Na/Ca) normalized by cell capacitance (pF)]. FK506 had no effects on membrane potential, I(Ca,L) and outward I(Na/Ca) in either mouse or rabbit VM. These results indicate that alteration of the functions of RyR by FK506-mediated dissociation of FKBP from RyR has different species-dependent effects on SR Ca2+ load and thus [Ca2+]i transients. This difference may result from the fact that [Na+]i is low in rabbit myocytes, allowing extrusion by Na+/Ca2+ exchange of Ca2+ released by FK506-induced dissociation of FKBP12.6 from SR RyR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12490609     DOI: 10.1124/jpet.102.041210

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  18 in total

Review 1.  Role of ryanodine receptor subtypes in initiation and formation of calcium sparks in arterial smooth muscle: comparison with striated muscle.

Authors:  Kirill Essin; Maik Gollasch
Journal:  J Biomed Biotechnol       Date:  2009-12-08

2.  Sensitized signalling between L-type Ca2+ channels and ryanodine receptors in the absence or inhibition of FKBP12.6 in cardiomyocytes.

Authors:  Yan-Ting Zhao; Yun-Bo Guo; Lei Gu; Xue-Xin Fan; Hua-Qian Yang; Zheng Chen; Peng Zhou; Qi Yuan; Guang-Ju Ji; Shi-Qiang Wang
Journal:  Cardiovasc Res       Date:  2017-03-01       Impact factor: 10.787

3.  Kinetics of FKBP12.6 binding to ryanodine receptors in permeabilized cardiac myocytes and effects on Ca sparks.

Authors:  Tao Guo; Razvan L Cornea; Sabine Huke; Emmanuel Camors; Yi Yang; Eckard Picht; Bradley R Fruen; Donald M Bers
Journal:  Circ Res       Date:  2010-04-29       Impact factor: 17.367

4.  Targeting of protein phosphatases PP2A and PP2B to the C-terminus of the L-type calcium channel Ca v1.2.

Authors:  Hui Xu; Kenneth S Ginsburg; Duane D Hall; Maike Zimmermann; Ivar S Stein; Mingxu Zhang; Samvit Tandan; Joseph A Hill; Mary C Horne; Donald Bers; Johannes W Hell
Journal:  Biochemistry       Date:  2010-11-11       Impact factor: 3.162

5.  Atrial fibrillation and electrophysiology in transgenic mice with cardiac-restricted overexpression of FKBP12.

Authors:  Zhenwei Pan; Tomohiko Ai; Po-Cheng Chang; Ying Liu; Jijia Liu; Mitsunori Maruyama; Mohamed Homsi; Michael C Fishbein; Michael Rubart; Shien-Fong Lin; Deyong Xiao; Hanying Chen; Peng-Sheng Chen; Weinian Shou; Bai-Yan Li
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-11-30       Impact factor: 4.733

6.  Effects of tacrolimus on action potential configuration and transmembrane ion currents in canine ventricular cells.

Authors:  László Szabó; Norbert Szentandrássy; Kornél Kistamás; Bence Hegyi; Ferenc Ruzsnavszky; Krisztina Váczi; Balázs Horváth; János Magyar; Tamás Bányász; Balázs Pál; Péter P Nánási
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-19       Impact factor: 3.000

7.  Regulation by FK506 and rapamycin of Ca2+ release from the sarcoplasmic reticulum in vascular smooth muscle: the role of FK506 binding proteins and mTOR.

Authors:  D MacMillan; J G McCarron
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

8.  Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis.

Authors:  Micah J Drummond; Christopher S Fry; Erin L Glynn; Hans C Dreyer; Shaheen Dhanani; Kyle L Timmerman; Elena Volpi; Blake B Rasmussen
Journal:  J Physiol       Date:  2009-02-02       Impact factor: 5.182

9.  Removal of FKBP12.6 does not alter the conductance and activation of the cardiac ryanodine receptor or the susceptibility to stress-induced ventricular arrhythmias.

Authors:  Jianmin Xiao; Xixi Tian; Peter P Jones; Jeff Bolstad; Huihui Kong; Ruiwu Wang; Lin Zhang; Henry J Duff; Anne M Gillis; Sidney Fleischer; Michael Kotlikoff; Julio A Copello; S R Wayne Chen
Journal:  J Biol Chem       Date:  2007-10-05       Impact factor: 5.157

10.  Half-Logistic Function Model for First Half of Descending Phase of Cardiomyocyte Cytoplasmic Ca(2+) Concentration ([Ca(2+)]i)-Time Curve (CaTCIII) in Isolated Aequorin-Injected Mouse Left Ventricular Papillary Muscle.

Authors:  Ju Mizuno; Mikiya Otsuji; Takeshi Yokoyama; Hideko Arita; Kazuo Hanaoka
Journal:  Acta Cardiol Sin       Date:  2016-01       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.